3 Top Healthcare Stocks to Buy in April

After all, if there are thousands of options that look pretty good at the moment, it can be hard to find companies that truly look great, especially in the long term, which is what matters. Genetic testing company Invitae (NYSE: NVTA) offers an array of saliva-based kits that doctors prescribe to consumers, who then collect and mail a sample from the comfort of their homes. For everything from cardiovascular disease risk to hereditary disorders, Invitae has a solution.